Page last updated: 2024-09-04

3,4-dihydro-5-methyl-1(2h)-isoquinolinone and s-nitro-n-acetylpenicillamine

3,4-dihydro-5-methyl-1(2h)-isoquinolinone has been researched along with s-nitro-n-acetylpenicillamine in 1 studies

Compound Research Comparison

Studies
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)
Trials
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)
Recent Studies (post-2010)
(3,4-dihydro-5-methyl-1(2h)-isoquinolinone)
Studies
(s-nitro-n-acetylpenicillamine)
Trials
(s-nitro-n-acetylpenicillamine)
Recent Studies (post-2010) (s-nitro-n-acetylpenicillamine)
160267722

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blaeser, K; Burkart, V; Kolb, H1

Other Studies

1 other study(ies) available for 3,4-dihydro-5-methyl-1(2h)-isoquinolinone and s-nitro-n-acetylpenicillamine

ArticleYear
Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1999, Volume: 31, Issue:12

    Topics: Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Islets of Langerhans; Isoquinolines; Kinetics; Niacinamide; Oxidative Stress; Penicillamine; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Wistar; Streptozocin

1999